AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
-25.74%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$791M
AUM Growth
+$791M
Cap. Flow
+$40.8M
Cap. Flow %
5.15%
Top 10 Hldgs %
95.26%
Holding
17
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
VIGL
Vigil Neuroscience
VIGL
$41M

Top Sells

1
COGT icon
Cogent Biosciences
COGT
$273K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KYMR icon
1
Kymera Therapeutics
KYMR
$2.95B
$291M 36.79%
6,875,698
– –
DYN icon
2
Dyne Therapeutics
DYN
$1.92B
$86.1M 10.89%
8,934,902
– –
DAWN icon
3
Day One Biopharmaceuticals
DAWN
$769M
$81.4M 10.29%
8,201,638
– –
GBIO icon
4
Generation Bio
GBIO
$40.4M
$60.8M 7.68%
8,278,876
– –
JBIO
5
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$56.9M 7.19%
3,103,879
– –
REPL icon
6
Replimune Group
REPL
$422M
$54.5M 6.89%
3,209,627
– –
VIGL
7
DELISTED
Vigil Neuroscience
VIGL
$41M 5.19%
+5,836,874
New +$41M
AKRO icon
8
Akero Therapeutics
AKRO
$3.74B
$31.7M 4%
2,232,251
– –
IMA
9
ImageneBio, Inc. Common Stock
IMA
$150M
$30.6M 3.87%
5,018,178
– –
XLO icon
10
Xilio Therapeutics
XLO
$36.3M
$19.5M 2.47%
2,759,344
– –
DNTH icon
11
Dianthus Therapeutics
DNTH
$759M
$10.1M 1.27%
3,476,536
– –
SPRO icon
12
Spero Therapeutics
SPRO
$116M
$8.97M 1.13%
1,031,160
– –
IRON icon
13
Disc Medicine
IRON
$2.07B
$7.3M 0.92%
5,254,365
– –
TECX
14
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$5.97M 0.75%
4,520,863
– –
FSTX
15
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.13M 0.27%
599,524
– –
VRDN icon
16
Viridian Therapeutics
VRDN
$1.5B
$1.67M 0.21%
90,072
– –
COGT icon
17
Cogent Biosciences
COGT
$1.69B
$1.4M 0.18%
186,487
-36,489
-16% -$273K